{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:03:52Z","timestamp":1793671432205,"version":"4.5.1"},"reference-count":369,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>One in 4 Americans &gt;40 years of age takes a statin to reduce the risk of myocardial infarction, ischemic stroke, and other complications of atherosclerotic disease. The most effective statins produce a mean reduction in low-density lipoprotein cholesterol of 55% to 60% at the maximum dosage, and 6 of the 7 marketed statins are available in generic form, which makes them affordable for most patients. Primarily using data from randomized controlled trials, supplemented with observational data where necessary, this scientific statement provides a comprehensive review of statin safety and tolerability. The review covers the general patient population, as well as demographic subgroups, including the elderly, children, pregnant women, East Asians, and patients with specific conditions such as chronic disease of the kidney and liver, human immunodeficiency viral infection, and organ transplants. The risk of statin-induced serious muscle injury, including rhabdomyolysis, is &lt;0.1%, and the risk of serious hepatotoxicity is \u22480.001%. The risk of statin-induced newly diagnosed diabetes mellitus is \u22480.2% per year of treatment, depending on the underlying risk of diabetes mellitus in the population studied. In patients with cerebrovascular disease, statins possibly increase the risk of hemorrhagic stroke; however, they clearly produce a greater reduction in the risk of atherothrombotic stroke and thus total stroke, as well as other cardiovascular events. There is no convincing evidence for a causal relationship between statins and cancer, cataracts, cognitive dysfunction, peripheral neuropathy, erectile dysfunction, or tendonitis. In US clinical practices, roughly 10% of patients stop taking a statin because of subjective complaints, most commonly muscle symptoms without raised creatine kinase. In contrast, in randomized clinical trials, the difference in the incidence of muscle symptoms without significantly raised creatine kinase in statin-treated compared with placebo-treated participants is &lt;1%, and it is even smaller (0.1%) for patients who discontinued treatment because of such muscle symptoms. This suggests that muscle symptoms are usually not caused by pharmacological effects of the statin. Restarting statin therapy in these patients can be challenging, but it is important, especially in patients at high risk of cardiovascular events, for whom prevention of these events is a priority. Overall, in patients for whom statin treatment is recommended by current guidelines, the benefits greatly outweigh the risks.<\/jats:p>","DOI":"10.1161\/atv.0000000000000073","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T08:44:02Z","timestamp":1547714642000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":673,"title":["Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association"],"prefix":"10.1161","volume":"39","author":[{"given":"Connie B.","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Tobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert L.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry B.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Tannock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Raghuveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Barton","family":"Duell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot A.","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine K.","family":"Welty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","unstructured":"World Health Organization. Cardiovascular Diseases Fact Sheet 2017. http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/. Accessed January 9 2018."},{"key":"e_1_3_2_3_2","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383\u20131389.","journal-title":"Lancet"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61350-5"},{"issue":"177","key":"e_1_3_2_6_2","first-page":"1","article-title":"Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003\u20132012.","author":"Gu Q","year":"2014","unstructured":"Gu, Q, Paulose-Ram, R, Burt, VL, Kit, BK. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003\u20132012. NCHS Data Brief. 2014;(177):1\u20138.","journal-title":"NCHS Data Brief"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-7-201304020-00004"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31532-X"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-7-201304020-00010"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1335"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.12.015"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6727-0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv641"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3283"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.036"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1112"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-4-200602210-00007"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422511"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03651-5"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31357-5"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04017-4"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800503"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38142.554479.AE"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.21.2585"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90004-5"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000251722"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.08.033"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801073180110"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801073180111"},{"key":"e_1_3_2_31_2","first-page":"48","article-title":"Reply to Norman et al. and East et al.","volume":"318","author":"Tobert JA","year":"1988","unstructured":"Tobert, JA. Reply to Norman et al. and East et al. N Engl J Med. 1988;318:48.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410030075032"},{"key":"e_1_3_2_33_2","first-page":"1225","article-title":"HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.","volume":"257","author":"Smith PF","year":"1991","unstructured":"Smith, PF, Eydelloth, RS, Grossman, SJ, Stubbs, RJ, Schwartz, MS, Germershausen, JI, Vyas, KP, Kari, PH, MacDonald, JS. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. J Pharmacol Exp Ther. 1991;257:1225\u20131235.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.5.553"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60716-8"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706201"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61240-4"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061894"},{"key":"e_1_3_2_39_2","first-page":"1","article-title":"Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.","volume":"9","author":"Armitage J","year":"2009","unstructured":"Armitage, J, Bowman, L, Collins, R, Parish, S, Tobert, J. Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people. BMC Clin Pharmacol. 2009;9:1\u201310.","journal-title":"BMC Clin Pharmacol"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60310-8"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001282"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050461"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02209-3"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.07.108"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90053-Z"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"e_1_3_2_49_2","unstructured":"Lubas W Parks M. FDA medical review(s): CRESTOR tablets NDA 21-366-N000 [resubmission amendment]. February 12 2003. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-366_Crestor_Medr_P1.pdf. Accessed October 15 2018."},{"key":"e_1_3_2_50_2","unstructured":"Chowdhury IN Gortler D. Pitavastatin clinical review NDA 22-363. 2009. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022363s000_MedR_P1.pdf. Accessed December 3 2016."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200202143460721"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960240902"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.09.003"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801936"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1287"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043545"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810177"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.08.012"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13638-0"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000230416.82349.90"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1249\/01.mss.0000210192.49210.fc"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1515161"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90218-3"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.08.045"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.074"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.136101"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.01.004"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2012.03.003"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060485"},{"key":"e_1_3_2_70_2","unstructured":"Roberts M. CRESTOR (Rosuvastatin calcium) NDA 21-366\/S-016; JUPITER; Briefing Document for United States Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee Meeting of December 15 2009. https:\/\/wayback.archive-it.org\/7993\/20170405221029\/https:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/EndocrinologicandMetabolicDrugsAdvisoryCommittee\/UCM193831.pdf. Accessed October 2 2016."},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487315602861"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.05.002"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.624890"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.03.019"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487314525531"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600176"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440170097011"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.01.016"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.7326\/M13-1921"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.09.007"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.08.006"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22518"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3608"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.12.016"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.11.005"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6723-4"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31075-9"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31163-7"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32427-3"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32423-6"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/ebmed-2017-110783"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2229"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2012.0459"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.115"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2012-131730"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.8342"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2017.01.006"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.01.003"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.01.031"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001133420212"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1566"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0838"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200012"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.10.118"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04321.x"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.702102"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2016.11.002"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001397"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2016.11.011"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.08.021"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.3.357"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X292029"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61190-8"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61965-6"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61183-1"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.047"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.860"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60104-X"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11600-X"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.06.024"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.06.001"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-011-0032-0"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.9.961"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-016-1647-9"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.1884"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1206"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604304"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.14568"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1179-5"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2008.029"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16895-5"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13636-7"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3374-x"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60697-8"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90003-3"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040752"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07486.x"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0182-7"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.02.011"},{"key":"e_1_3_2_140_2","unstructured":"U.S. Food and Drug Administration. 2012: FDA Drug Safety Communication: important safety label changes to cholesterol-lowering statin drugs. http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm293101.htm. Accessed September 20 2016."},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1711"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1240010"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.07.023"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151587"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000350"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198904063201405"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg106"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60834-3"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.055269"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70058-4"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.041"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15690-0"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d6476a"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.02.013"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.35"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003160.pub3"},{"key":"e_1_3_2_157_2","first-page":"284","article-title":"The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.","volume":"35","author":"Eckern\u00e4s SA","year":"1993","unstructured":"Eckern\u00e4s, SA, Roos, BE, Kvidal, P, Eriksson, LO, Block, GA, Neafus, RP, Haigh, JR. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia. Br J Clin Pharmacol. 1993;35:284\u2013289.","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_2_158_2","first-page":"643","article-title":"Effect of pravastatin on human sleep.","volume":"47","author":"Kamei Y","year":"1993","unstructured":"Kamei, Y, Shirakawa, S, Ishizuka, Y, Usui, A, Uchiyama, M, Watanabe, T, Fukuzawa, H, Kariya, T. Effect of pravastatin on human sleep. Jpn J Psychiatry Neurol. 1993;47:643\u2013646.","journal-title":"Jpn J Psychiatry Neurol"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1994.tb01971.x"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90814-1"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960150607"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.09.082"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1758-y"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730060-00005"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2012.732078"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2016.04.046"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2015.07.025"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16508-2"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280000248"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.9.1333"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2003.013409"},{"key":"e_1_3_2_172_2","first-page":"688","article-title":"Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up.","volume":"32","author":"Otruba P","year":"2011","unstructured":"Otruba, P, Kanovsky, P, Hlustik, P. Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up. Neuro Endocrinol Lett. 2011;32:688\u2013690.","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0919-2"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70173-1"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12013"},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.18.6291"},{"key":"e_1_3_2_177_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1011900"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb01293.x"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90182-5"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2000.7716a"},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(00)90938-7"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12497"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12521"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.7.8635"},{"key":"e_1_3_2_185_2","first-page":"494","article-title":"Cataracts produced by triparanol (MER-29).","volume":"65","author":"Kirby TJ","year":"1967","unstructured":"Kirby, TJ. Cataracts produced by triparanol (MER-29). Trans Am Ophthalmol Soc. 1967;65:494\u2013543.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80596-0"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199009063231015"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90002-3"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.09.026"},{"key":"e_1_3_2_190_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2197"},{"key":"e_1_3_2_191_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.4575"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.08.001"},{"key":"e_1_3_2_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.11.027"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000138236.82706.EE"},{"key":"e_1_3_2_195_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.01.016"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.11.072"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f880"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.03.046"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0245"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31823c074e"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507750"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0548"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.040766"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(01)00300-1"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.02.068"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23309"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja15.00806"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e3181a0ce8b"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1142\/S0218810412500153"},{"key":"e_1_3_2_210_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000039"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1177\/0363546515588173"},{"key":"e_1_3_2_212_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(95)90076-4"},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351401"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000017634.00171.24"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029849"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16936-5"},{"key":"e_1_3_2_217_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61125-2"},{"key":"e_1_3_2_218_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072642"},{"key":"e_1_3_2_219_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018580"},{"key":"e_1_3_2_220_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019014"},{"key":"e_1_3_2_221_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1201735"},{"key":"e_1_3_2_222_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000456"},{"key":"e_1_3_2_223_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-6618(95)80042-5"},{"key":"e_1_3_2_224_2","doi-asserted-by":"publisher","DOI":"10.1358\/mf.2003.25.6.769652"},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.02.010"},{"key":"e_1_3_2_226_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602539009041088"},{"key":"e_1_3_2_227_2","first-page":"410","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.","volume":"27","author":"Fischer V","year":"1999","unstructured":"Fischer, V, Johanson, L, Heitz, F, Tullman, R, Graham, E, Baldeck, JP, Robinson, WT. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions. Drug Metab Dispos. 1999;27:410\u2013416.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_2_228_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002857"},{"key":"e_1_3_2_229_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380200067023"},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111495"},{"key":"e_1_3_2_231_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.13.4124"},{"key":"e_1_3_2_232_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(75)90182-8"},{"key":"e_1_3_2_233_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.41"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.163"},{"key":"e_1_3_2_235_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03996.x"},{"key":"e_1_3_2_236_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02095.x"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1053\/cp.1999.v66.a101208"},{"key":"e_1_3_2_238_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.110216"},{"key":"e_1_3_2_239_2","doi-asserted-by":"publisher","DOI":"10.2174\/187231207779814247"},{"key":"e_1_3_2_240_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.08.076"},{"key":"e_1_3_2_241_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.11.1280"},{"key":"e_1_3_2_242_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0872"},{"key":"e_1_3_2_243_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-8-201004200-00005"},{"key":"e_1_3_2_244_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.181946"},{"key":"e_1_3_2_245_2","unstructured":"National Heart Lung and Blood Institute. Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Full Report. 2011. https:\/\/www.nhlbi.nih.gov\/node\/80139. Accessed June 17 2018."},{"key":"e_1_3_2_246_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1349"},{"key":"e_1_3_2_247_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000297"},{"key":"e_1_3_2_248_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-015-0629-1"},{"key":"e_1_3_2_249_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006401.pub3"},{"key":"e_1_3_2_250_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.6176"},{"key":"e_1_3_2_251_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.05.006"},{"key":"e_1_3_2_252_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.2.137"},{"key":"e_1_3_2_253_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000035247.42888.82"},{"key":"e_1_3_2_254_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(03)00186-0"},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.042"},{"key":"e_1_3_2_256_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.05.034"},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.3.331"},{"key":"e_1_3_2_258_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1541"},{"key":"e_1_3_2_259_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2090"},{"key":"e_1_3_2_260_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-008-9364-3"},{"key":"e_1_3_2_261_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-869588"},{"key":"e_1_3_2_262_2","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12245"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.30645"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08350813"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.144"},{"key":"e_1_3_2_266_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2010.523736"},{"key":"e_1_3_2_267_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.79"},{"key":"e_1_3_2_268_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1800-0"},{"key":"e_1_3_2_269_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1801-z"},{"key":"e_1_3_2_270_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.115"},{"key":"e_1_3_2_271_2","first-page":"187","article-title":"Phase I study of ZD4522 (rosuvastatin), a new HMG-CoA reductase inhibitor: evaluation of tolerance and pharmacokinetics in healthy adult male volunteers after single and repeated oral administration.","volume":"21","author":"Senkino H","year":"2005","unstructured":"Senkino, H, Onishi, T. Phase I study of ZD4522 (rosuvastatin), a new HMG-CoA reductase inhibitor: evaluation of tolerance and pharmacokinetics in healthy adult male volunteers after single and repeated oral administration. J Clin Ther Med. 2005;21:187\u2013203.","journal-title":"J Clin Ther Med"},{"key":"e_1_3_2_272_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.06.013"},{"key":"e_1_3_2_273_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12884"},{"key":"e_1_3_2_274_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300955"},{"key":"e_1_3_2_275_2","doi-asserted-by":"publisher","DOI":"10.2165\/11592480-000000000-00000"},{"key":"e_1_3_2_276_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht055"},{"key":"e_1_3_2_277_2","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420280316"},{"key":"e_1_3_2_278_2","first-page":"72064","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling: Final rule.","volume":"79","author":"Food and Drug Administration, HHS","year":"2014","unstructured":"Food and Drug Administration, HHS. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling: Final rule. Fed Regist. 2014;79:72064\u201372103.","journal-title":"Fed Regist"},{"key":"e_1_3_2_279_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20181"},{"key":"e_1_3_2_280_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20005"},{"key":"e_1_3_2_281_2","doi-asserted-by":"publisher","DOI":"10.1586\/erc.11.196"},{"key":"e_1_3_2_282_2","doi-asserted-by":"publisher","DOI":"10.1586\/17474108.2013.842684"},{"key":"e_1_3_2_283_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.07.002"},{"key":"e_1_3_2_284_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.08.007"},{"key":"e_1_3_2_285_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.03.452"},{"key":"e_1_3_2_286_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111618"},{"key":"e_1_3_2_287_2","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.86.484"},{"key":"e_1_3_2_288_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-5-609"},{"key":"e_1_3_2_289_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.08.008"},{"key":"e_1_3_2_290_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-10-94"},{"key":"e_1_3_2_291_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.06.029"},{"key":"e_1_3_2_292_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000296277.63350.77"},{"key":"e_1_3_2_293_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.356"},{"key":"e_1_3_2_294_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.2124"},{"key":"e_1_3_2_295_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143892.84582.60"},{"key":"e_1_3_2_296_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3"},{"key":"e_1_3_2_297_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30156-5"},{"key":"e_1_3_2_298_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.11.015"},{"key":"e_1_3_2_299_2","first-page":"261","article-title":"Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.","volume":"12","author":"Ak\u00e7i\u00e7ek F","year":"1996","unstructured":"Ak\u00e7i\u00e7ek, F, Ok, E, Duman, S, K\u00fcrsad, S, Unsal, A, Alev, M, Atabay, G, Bas\u00e7i, A. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Adv Perit Dial. 1996;12:261\u2013265.","journal-title":"Adv Perit Dial"},{"key":"e_1_3_2_300_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00262.x"},{"key":"e_1_3_2_301_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.5.684"},{"key":"e_1_3_2_302_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1993.tb01727.x"},{"key":"e_1_3_2_303_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.30547"},{"key":"e_1_3_2_304_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013090965"},{"key":"e_1_3_2_305_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.08.060"},{"key":"e_1_3_2_306_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62142-3"},{"key":"e_1_3_2_307_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.02.015"},{"key":"e_1_3_2_308_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200502000-00002"},{"key":"e_1_3_2_309_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171"},{"key":"e_1_3_2_310_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.128"},{"key":"e_1_3_2_311_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws448"},{"key":"e_1_3_2_312_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2415"},{"key":"e_1_3_2_313_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21848"},{"key":"e_1_3_2_314_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i25.7860"},{"key":"e_1_3_2_315_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-010-0203-y"},{"key":"e_1_3_2_316_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31819c392e"},{"key":"e_1_3_2_317_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.013"},{"key":"e_1_3_2_318_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28506"},{"key":"e_1_3_2_319_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.10.007"},{"key":"e_1_3_2_320_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2012.07267.x"},{"key":"e_1_3_2_321_2","doi-asserted-by":"publisher","DOI":"10.1159\/000354541"},{"key":"e_1_3_2_322_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080304"},{"key":"e_1_3_2_323_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.337"},{"key":"e_1_3_2_324_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.179"},{"key":"e_1_3_2_325_2","doi-asserted-by":"publisher","DOI":"10.1086\/378131"},{"key":"e_1_3_2_326_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.3728"},{"key":"e_1_3_2_327_2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Living With HIV. Department of Health and Human Services. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. Accessed October 26 2016."},{"key":"e_1_3_2_328_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30075-9"},{"key":"e_1_3_2_329_2","first-page":"146","article-title":"HIV-related cardiovascular disease, statins, and the REPRIEVE trial.","volume":"23","author":"Gilbert JM","year":"2015","unstructured":"Gilbert, JM, Fitch, KV, Grinspoon, SK. HIV-related cardiovascular disease, statins, and the REPRIEVE trial. Top Antivir Med. 2015;23:146\u2013149.","journal-title":"Top Antivir Med"},{"key":"e_1_3_2_330_2","first-page":"S234","article-title":"Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound.","volume":"14","author":"Valantine HA","year":"1995","unstructured":"Valantine, HA. Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound. J Heart Lung Transplant. 1995;14:S234\u2013S237.","journal-title":"J Heart Lung Transplant"},{"key":"e_1_3_2_331_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.08.003"},{"key":"e_1_3_2_332_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.08.002"},{"key":"e_1_3_2_333_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04236.x"},{"key":"e_1_3_2_334_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02414.x"},{"key":"e_1_3_2_335_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318160254f"},{"key":"e_1_3_2_336_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03691.x"},{"key":"e_1_3_2_337_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.27084"},{"key":"e_1_3_2_338_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04099.x"},{"key":"e_1_3_2_339_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000266898.93894.3d"},{"key":"e_1_3_2_340_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2000.00112.x"},{"key":"e_1_3_2_341_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199601150-00011"},{"key":"e_1_3_2_342_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21588"},{"key":"e_1_3_2_343_2","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(89)90107-0"},{"key":"e_1_3_2_344_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)98884-8"},{"key":"e_1_3_2_345_2","doi-asserted-by":"publisher","DOI":"10.1016\/0162-3109(96)00108-7"},{"key":"e_1_3_2_346_2","first-page":"335","article-title":"The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.","volume":"17","author":"Katznelson S","year":"1998","unstructured":"Katznelson, S, Wang, XM, Chia, D, Ozawa, M, Zhong, HP, Hirata, M, Terasaki, PI, Kobashigawa, JA. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. J Heart Lung Transplant. 1998;17:335\u2013340.","journal-title":"J Heart Lung Transplant"},{"key":"e_1_3_2_347_2","doi-asserted-by":"publisher","DOI":"10.1038\/82219"},{"key":"e_1_3_2_348_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00123-7"},{"key":"e_1_3_2_349_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509073331003"},{"key":"e_1_3_2_350_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2007.00827.x"},{"key":"e_1_3_2_351_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01105.x"},{"key":"e_1_3_2_352_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90340-S"},{"key":"e_1_3_2_353_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00077-2"},{"key":"e_1_3_2_354_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(01)00369-2"},{"key":"e_1_3_2_355_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000043241.32523.ee"},{"key":"e_1_3_2_356_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00128-5"},{"key":"e_1_3_2_357_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02340-9"},{"key":"e_1_3_2_358_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015052312866"},{"key":"e_1_3_2_359_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318174428d"},{"key":"e_1_3_2_360_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.1.141"},{"key":"e_1_3_2_361_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.09.163"},{"key":"e_1_3_2_362_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.02.071"},{"key":"e_1_3_2_363_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199610150-00011"},{"key":"e_1_3_2_364_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D388"},{"key":"e_1_3_2_365_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00044-7"},{"key":"e_1_3_2_366_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2007.00780.x"},{"key":"e_1_3_2_367_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181910eb2"},{"key":"e_1_3_2_368_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(01)00251-0"},{"key":"e_1_3_2_369_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(03)00193-1"},{"key":"e_1_3_2_370_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(02)00455-2"}],"updated-by":[{"DOI":"10.1161\/atv.0000000000000081","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000}}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/ATV.0000000000000073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T19:04:24Z","timestamp":1715540664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/ATV.0000000000000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":369,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1161\/ATV.0000000000000073"],"URL":"https:\/\/doi.org\/10.1161\/atv.0000000000000073","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734683567.793577308","asserted-by":"object"}]},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"2018-12-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}